N-Acetyltransferase 2 (NAT2) Polymorphism in Patients with Atopic Asthma

Archives of Medical Research

Volumn 40, Issue 4, 2009, Pages 264-267

  Pawlik, Andrzej ^a   Juzyszyn, Zygmunt ^a   Gawronska Szklarz, Barbara ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Atopic asthma; Genetic factors; NAT2 polymorphism

Indexed keywords

ALLERGEN; ARYLAMINE ACETYLTRANSFERASE; XENOBIOTIC AGENT;

ACETYLATOR PHENOTYPE; ADULT; ALLERGIC ASTHMA; ARTICLE; CHRONIC INFLAMMATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG DETOXIFICATION; ENVIRONMENTAL FACTOR; ENZYME POLYMORPHISM; FEMALE; GENE MUTATION; GENOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; RESPIRATORY TRACT INFLAMMATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; XENOBIOTIC METABOLISM;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; ASTHMA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 67650096958     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.03.003     Document Type: Article

References (38)

1. Bener A., Ehlayel M., and Sabbah A. The pattern and genetics of pediatric extrinsic asthma risk factors in polluted environment. Allerg Immunol 39 (2007) 58-63
2. Gern J.E. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J 27 10 suppl (2008) S97-S103
3. Kabesch M., Depner M., Dahmen I., et al. Polymorphisms in eosinophil pathway genes, asthma and atopy. Allergy 62 (2007) 423-428
4. Saglani S., and Bush A. The early-life origins of asthma. Curr Opin Allergy Clin Immunol 7 (2007) 83-90
5. Daly A.K., Cholerton S., Armstrong M., and Idle J.R. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 102 suppl 9 (1994) 55-61
6. Safuanova G.S. Polymorphism of xenobiotic detoxication genes in patients with iron deficiency anemia. Klin Lab Diagn 7 (2003) 40-42
7. Fogel W.A., Lewinski A., and Jochem J. Histamine in food: is there anything to worry about?. Biochem Soc Trans 35 (2007) 349-352
8. Seiler N. Catabolism of polyamines. Amino Acids 26 (2004) 217-233
9. Mitchell K.R., and Warshawsky D. Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes. Toxicol Lett 139 (2003) 11-23
10. Delomenie C., Sica L., Grant D.M., Krishnamoorthy R., and Dupret J.M. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations. Pharmacogenetics 6 (1996) 177-185
11. Hein D.W., Ferguson R.J., Doll M.A., Rustan T.D., and Gray K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 3 (1994) 729-734
12. Sabbagh A., Langaney A., Darlu P., Gérard N., Krishnamoorthy R., and Poloni E.S. Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history. BMC Genet 9 (2008) 21
13. Spielberg S.P. N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism. J Pharmacokinet Biopharm 24 (1996) 509-519
14. Rychlik-Sych M., Skretkowicz J., Gawronska-Szklarz B., Górnik W., Sysa-Jedrzejowska A., and Skretkowicz-Szarmach K. Acetylation genotype and phenotype in patients with systemic lupus erythematosus. Pharmacol Rep 58 (2006) 22-29
15. Kumagi S., Komada F., Kita T., et al. N-acetyltransferase 2 genotype-related efficacy of sulfasalazine in patients with rheumatoid arthritis. Pharm Res 21 (2004) 324-329
16. Tamer L., Ercan B., Ates N.A., et al. N-acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma. Cell Biochem Funct 24 (2006) 131-135
17. Crabtree M.D., Fletcher C., Churchman M., Hodgson S.V., Neale K., Phillips R.K., et al. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases GUT 53 (2004) 271-276
18. Patkowski J., Malolepszy J., Milejski P., Orzechowska-Juzwenko K., and Nittner-Marszalska M. Acetylation phenotype in atopic diseases. Pol Tyg Lek 42 (1987) 870-873
19. Zielinska E., Niewiarowski W., Bodalski J., Stanczyk A., Bolanowski W., and Rebowski G. Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases. Clin Pharmacol Ther 62 (1997) 635-642
20. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report, NIH Publication No. 02-3659, February 2002.
21. Gawronska-Szklarz B., Luszawska-Kutrzeba T., Czaja-Bulsa G., and Kurzawski G. Relationship between acetylation polymorphism and risk of atopic diseases. Clin Pharmacol Ther 65 (1999) 562-569
22. Gustincich S., Manfioletti G., Del Sal G., Schneider C., and Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 11 (1991) 298-302
23. Spurr N.K., Gough A.C., Chinegwundoh F.I., and Smith C.A. Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk. Clin Chem 41 (1995) 1864-1869
24. Mrozikiewicz P.M., Cascorbi I., Brockmöller J., and Roots I. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population. Clin Pharmacol Ther 59 (1996) 376-382
25. Gawronska-Szklarz B., Pawlik A., Czaja-Bulsa G., Górnik W., Luszawska-Kutrzeba T., and Wrzesniewska J. Genotype of N-acetyltransferase 2 (NAT2) polymorphism in children with immunoglobulin E-mediated food allergy. Clin Pharmacol Ther 69 (2001) 372-378
26. Wikman H., Piirila P., Rosenberg C., et al. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 12 (2002) 227-233
27. Nacak M., Aynacioglu A.S., Filiz A., et al. Association between the N-acetylation genetic polymorphism and bronchial asthma. Br J Clin Pharmacol 54 (2002) 671-674
28. Batra J., Sharma S.K., and Ghosh B. Arylamine N-acetyltransferase gene polymorphisms: markers for atopic asthma, serum IgE and blood eosinophil counts. Pharmacogenomics 7 (2006) 673-682
29. Tamer L., Calikoglu M., Aras Ates N., Yildirim H., Karakas S., and Atik U. Relationship between N-acetyl transferase-2 gene polymorphism and risk of bronchial asthma. Tuberk Toraks 54 (2006) 137-143
30. Makarova S.I., Vavilin V.A., Lyakhovich V.V., and Gavalov S.M. Allele NAT2*5 determines resistance to bronchial asthma in children. Bull Exp Biol Med 129 (2000) 575-577
31. Kopferschmitt-Kubler M.C., Frossard N., Rohde G., and Pauli G. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma: a pilot study. Respir Med 92 (1998) 1093-1098
32. Meredith S.K., Bugler J., and Clark R.L. Isocyanate exposure and occupational asthma: a case-referent study. Occup Environ Med 57 (2000) 830-836
33. Klein D.C. Arylalkylamine N-acetyltransferase: "the Timenzyme". J Biol Chem 282 (2007) 4233-4237
34. Ménard G., Turmel V., and Bissonnette E.Y. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol 150 (2007) 340-348
35. Bayer H., Mueller T., Myrtek D., et al. Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol 36 (2007) 85-93
36. Garcia-Maurino S., Gonzalez-Haba M.G., Calvo J.R., et al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 159 (1997) 574-581
37. Sutherland E.R., Ellison M.C., Kraft M., and Martin R.J. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 112 (2003) 513-517
38. Rahamimoff R., and Bruderman I. Changes in pulmonary mechanics induced by melatonin. Life Sci 4 (1965) 1383-1389